substance p has been researched along with Esophageal Squamous Cell Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, AR; Hashemy, SI; Javid, H; Mashkani, B; Mohammadi, F | 1 |
| Cai, L; Feng, F; Guo, M; Guo, Y; Lian, X; Liu, J; Liu, S; Wang, F; Wang, Q; Xu, G; Zhang, H; Zhang, W; Zheng, G | 1 |
2 other study(ies) available for substance p and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Topics: Apoptosis; Aprepitant; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.
Topics: Animals; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Mice; Receptors, Neurokinin-1; Substance P; Transcription Factor HES-1; Tumor Cells, Cultured | 2019 |